Latest News
- June 05, 2025Join CBCC at CPHI China 2025
- June 02, 2025Successfully completed a Phase 1a study for a US-based Innovator Biotech Company!
- May 26, 2025ANDA application for Paclitaxel Injection (Albumin bound) supported by CBCC has received Marketing Authorization from the USFDA
- May 20, 2025We’re Exhibiting at BIO 2025! Visit our booth #3480
- May 15, 2025Join CBCC Global Research at #ASCO25
May 09, 2024
Successful completion of 9 USFDA inspections
CBCC Global Research is proud to announce successful completion of 9 USFDA inspections since April 2022 for Oncology trials.
This is a result of commitment, hard work and dedication of our team towards our goal: CHANGING LIVES THROUGH HOPE AND INNOVATION